A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery ...

Teddy bears offer emotional comfort and connection for adults with cancer, easing anxiety and fostering trust during ...

A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following ...

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Ghoreifi works with the House Staff and is a part of Duke Urologic Oncology Fellowship, Duke Urology, at Duke School of Medicine, located in Durham, North Caroline.

CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven ...

A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue ...

Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality ...

The FDA has granted approval to treatment with Tepylute, a ready-to-dilute version of thiotepa, at 100 mg for breast and ...